Semaglutide and tirzepatide lead to better blood sugar control and weight loss in type 1 diabetes, study finds
Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight or obesity, research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) held in Madrid, Spain (9–13 September) has found.
Source: Medical Xpress
